Navigating Insurance Denials: A Personal Battle for Lifesaving Treatment

Navigating Insurance Denials: A Personal Battle for Lifesaving Treatment

This week, I’m stepping away from my usual updates on the Social Determinants of Health (SDoH) to share a deeply personal experience. I hope that by bringing this issue to light, we can foster collective growth and learning.

Although I typically keep my personal medical journey private, recent events have compelled me to speak out.

In January 2019, I was diagnosed with Stage 3 Hodgkin lymphoma. Since then, I’ve undergone various treatments, including a stem-cell transplant. Fortunately, for the past two years, a drug called Keytruda has helped keep my cancer at bay, with minimal side effects and significant remission. However, about a month ago, I was blindsided by a denial from my insurance company. The denial came because I had reached the two-year mark on Keytruda, which is the period the insurance company deemed sufficient.

This decision was not only surprising but also disheartening. Despite significant help in filing an appeal from Dr. Kendall Smith at PayerWatch, and my husband, Ryan O’Hara, spending over 18 hours on calls with CareFirst BlueCross BlueShield and CVS Caremark, and presenting evidence from recent studies, my efforts to overturn this denial have been unsuccessful. The insurance company has opted to rely on a four-year-old clinical study rather than the most recent research, which demonstrates that Keytruda continues to be effective, with a 22-percent full remission rate as of Sept. 7, 2023.

The denial of lifesaving treatment by these for-profit entities is a stark reminder of the challenges many face in accessing necessary healthcare. This is not merely about my personal treatment, but a broader issue affecting countless individuals. My oncologist, a respected expert at Mayo Clinic, has prescribed this treatment based on its proven effectiveness and cost-efficiency. Yet, it appears that my insurance has prioritized cost savings over long-term healthcare effectiveness.

As someone who obviously works in the healthcare field, I am familiar with the complexities of navigating this system. I am actively working on alternative plans, but this situation demonstrates a harsh reality: many people lack the resources or knowledge to advocate for themselves effectively. This denial of care, despite my access to support and expertise, raises serious questions about how patients without such resources cope with similar challenges.

The frustration of dealing with an insurance company that seems more concerned with cutting costs than saving lives is compounded by the personal stakes involved. This is not just about me; it’s about the broader issue of insurance companies dictating the terms of care, often while overriding the recommendations of dedicated medical professionals.

In sharing my story, I hope to shed light on this critical issue and encourage a dialogue about the need for systemic change. No one should have to fight for access to lifesaving treatment, and no healthcare decision should be driven by profit rather than patient welfare. The goal should always be to ensure that every patient receives the care they need.

References:

Armand P, Zinzani PL, Lee HJ, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Herrera AF, Lin J, Kim E, Chakraborty S, Marinello P, Moskowitz CH. Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma. Blood. 2023 Sep 7;142(10):878-886. doi: 10.1182/blood.2022019386. PMID: 37319435; PMCID: PMC10624931

EDITOR’S NOTE:

The opinions expressed in this article are solely those of the author and do not necessarily represent the views or opinions of MedLearn Media. We provide a platform for diverse perspectives, but the content and opinions expressed herein are the author’s own. MedLearn Media does not endorse or guarantee the accuracy of the information presented. Readers are encouraged to critically evaluate the content and conduct their own research. Any actions taken based on this article are at the reader’s own discretion.

Facebook
Twitter
LinkedIn

Tiffany Ferguson, LMSW, CMAC, ACM

Tiffany Ferguson is CEO of Phoenix Medical Management, Inc., the care management company. Tiffany serves on the ACPA Observation Subcommittee. Tiffany is a contributor to RACmonitor, Case Management Monthly, and commentator for Finally Friday. After practicing as a hospital social worker, she went on to serve as Director of Case Management and quickly assumed responsibilities in system level leadership roles for Health and Care Management and c-level responsibility for a large employed medical group. Tiffany received her MSW at UCLA. She is a licensed social worker, ACM, and CMAC certified.

Related Stories

H.R. 1 Impact on Coding

H.R. 1 Impact on Coding

H.R. 1 doesn’t directly rewrite ICD-10 or CPT, but it does change the environment in which you’re coding. The impact is mostly indirect – through

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Mastering Principal Diagnosis: Coding Precision, Medical Necessity, and Quality Impact

Mastering Principal Diagnosis: Coding Precision, Medical Necessity, and Quality Impact

Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.

December 3, 2025

Proactive Denial Management: Data-Driven Strategies to Prevent Revenue Loss

Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.

November 25, 2025
Sepsis: Bridging the Clinical Documentation and Coding Gap to Reduce Denials

Sepsis: Bridging the Clinical Documentation and Coding Gap to Reduce Denials

Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.

September 24, 2025

Trending News

Featured Webcasts

Surviving Federal Audits for Inpatient Rehab Facility Services

Surviving Federal Audits for Inpatient Rehab Facility Services

Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.

November 13, 2025
E/M Services Under Intensive Federal Scrutiny: Navigating Split/Shared, Incident-to & Critical Care Compliance in 2025-2026

E/M Services Under Intensive Federal Scrutiny: Navigating Split/Shared, Incident-to & Critical Care Compliance in 2025-2026

During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.

August 26, 2025

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24